Increase in serum ceruloplasmin levels is correlated with a decrease of serum nitric oxide levels in type 2 diabetes [3]

Diabetes Care

Volumn 23, Issue 4, 2000, Pages 559-560

  Daimon, Makoto ^a   Sugiyama, Kazuhiko ^b   Saitoh, Tamotsu ^a   Yamaguchi, Hiroshi ^a   Hirata, Akihiko ^a   Ohnuma, Hiroshi ^a   Igarashi, Masahiko ^a   Eguchi, Hideyuki ^a   Manaka, Hideo ^a   Kato, Takeo ^a  

^a YAMAGATA UNIVERSITY   (Japan)

^b Yamagata Saisei Hospital   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CERULOPLASMIN; NITRIC OXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LETTER; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATION;

EID: 18544412076     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.23.4.559     Document Type: Letter

References (6)

1. Danks DM: Disorder of copper transport. In The Metabolic and Molecular Basis of Inherited Disease. 7th ed. Scriver CR, Beaudet AL, Sly WS, Valle D, Eds. New York, McGraw-Hill, 1995, p. 2211-2236
2. Ehrenwald E, Chisolm GM, Fox PL: Intact human ceruloplasmin oxidatively modifies low density lipoprotein. J Clin Invest 93:1493-1501, 1994
3. Chobanian AV: Pathophysiology of atherosclerosis. Am J Cardiol 70:3G-7G, 1992
4. Daimon M, Susa S, Yamatani K, Manaka H, Hama K, Kimura M, Ohnuma H, Kato T: Hyperglycemia is a factor for an increase in serum ceruloplasmin in type 2 diabetes. Diabetes Care 21:1525-1528, 1998
5. Liao JK, Shin WS, Lee WY, Clark SL: Oxidized low-density lipoprotein decreases the expression of endothelial nitric oxide synthase. J Biol Chem 270:319-324, 1995
6. Vanhoutte PM: Endothelial dysfunction and atherosclerosis. Eur Heart J 18 (Suppl. E): E19-E29, 1997